Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-08-31 Sale | 2026-09-01 4:22 pm | RHYTHM PHARMACEUTICALS INC. | RYTM | Smith Hunter C Chief Financial Officer | 62,774 | $105.46 | $6,619,913 | 117,837 (Direct) | View |
| 2026-08-13 Sale | 2026-08-17 6:00 pm | RHYTHM PHARMACEUTICALS INC. | RYTM | Shulman Joseph Chief Technical Officer | 5,079 | $119.75 | $608,210 | 21,860 (Direct) | View |
| 2026-08-13 Sale | 2026-08-17 5:57 pm | RHYTHM PHARMACEUTICALS INC. | RYTM | Garfield Alastair Chief Scientific Officer | 7,763 | $117.57 | $912,703 | 2,295 (Direct) | View |
| 2026-08-13 Sale | 2026-08-14 7:04 pm | RHYTHM PHARMACEUTICALS INC. | RYTM | Lee Jennifer Kayden EVP, Head of North America | 75,834 | $117.38 | $8,901,531 | 36,283 (Direct) | View |
| 2026-08-12 Sale | 2026-08-14 7:01 pm | RHYTHM PHARMACEUTICALS INC. | RYTM | Mazabraud Yann EVP, Head of International | 57,000 | $116.15 | $6,620,575 | 91,530 (Direct) | View |
| 2026-06-22 Sale | 2026-06-24 4:15 pm | RHYTHM PHARMACEUTICALS INC. | RYTM | TETRAULT LYNN A. Director | 37,000 | $100.32 | $3,711,896 | 7,000 (Direct) | View |
| 2026-05-15 Sale | 2026-05-19 4:15 pm | RHYTHM PHARMACEUTICALS INC. | RYTM | German Christopher Paul Corporate Controller & CAO | 4,643 | $92.21 | $428,131 | 8,739 (Direct) | View |
| 2026-03-04 Sale | 2026-03-06 4:51 pm | RHYTHM PHARMACEUTICALS INC. | RYTM | German Christopher Paul Corporate Controller & CAO | 5,614 | $89.56 | $502,790 | 3,891 (Direct) | View |
| 2026-02-17 Sale | 2026-02-19 9:02 pm | RHYTHM PHARMACEUTICALS INC. | RYTM | Smith Hunter C Chief Financial Officer | 7,954 | $101.31 | $805,814 | 110,512 (Direct) | View |
| 2026-02-10 Sale | 2026-02-12 8:56 pm | RHYTHM PHARMACEUTICALS INC. | RYTM | Smith Hunter C Chief Financial Officer | 7,071 | $100.21 | $708,576 | 180,966 (Direct) | View |
| 2026-02-04 Sale | 2026-02-06 6:38 pm | RHYTHM PHARMACEUTICALS INC. | RYTM | Smith Hunter C Chief Financial Officer | 6,628 | $106.03 | $702,744 | 125,537 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-08-31 Exercise | 2026-09-01 4:22 pm | N/A N/A | RHYTHM PHARMACEUTICALS INC. | RYTM | Smith Hunter C Chief Financial Officer | 57,187 | $25.79 | 117,837 (Direct) | View |
| 2026-08-31 Exercise | 2026-09-01 4:22 pm | N/A 2028-02-13 | RHYTHM PHARMACEUTICALS INC. | RYTM | Smith Hunter C Chief Financial Officer | 57,187 | $0 | 117,837 (Direct) | View |
| 2026-08-17 Option Award | 2026-08-18 5:35 pm | N/A 2036-08-16 | RHYTHM PHARMACEUTICALS INC. | RYTM | Joshi Manher Chief Medical Officer | 75,000 | $0 | 75,000 (Direct) | View |
| 2026-08-13 Exercise | 2026-08-17 6:00 pm | N/A N/A | RHYTHM PHARMACEUTICALS INC. | RYTM | Shulman Joseph Chief Technical Officer | 2,024 | $6.8 | 21,860 (Direct) | View |
| 2026-08-13 Exercise | 2026-08-17 6:00 pm | N/A 2032-02-08 | RHYTHM PHARMACEUTICALS INC. | RYTM | Shulman Joseph Chief Technical Officer | 2,024 | $0 | 21,860 (Direct) | View |
| 2026-08-13 Exercise | 2026-08-14 7:04 pm | N/A N/A | RHYTHM PHARMACEUTICALS INC. | RYTM | Lee Jennifer Kayden EVP, Head of North America | 21,601 | $6.8 | 36,283 (Direct) | View |
| 2026-08-13 Exercise | 2026-08-14 7:04 pm | N/A 2030-11-09 | RHYTHM PHARMACEUTICALS INC. | RYTM | Lee Jennifer Kayden EVP, Head of North America | 56,601 | $0 | 36,283 (Direct) | View |
| 2026-08-13 Exercise | 2026-08-14 7:04 pm | N/A N/A | RHYTHM PHARMACEUTICALS INC. | RYTM | Lee Jennifer Kayden EVP, Head of North America | 35,000 | $24.29 | 36,283 (Direct) | View |
| 2026-08-12 Exercise | 2026-08-14 7:01 pm | N/A N/A | RHYTHM PHARMACEUTICALS INC. | RYTM | Mazabraud Yann EVP, Head of International | 46,625 | $6.8 | 91,530 (Direct) | View |
| 2026-08-12 Exercise | 2026-08-14 7:01 pm | N/A 2032-02-08 | RHYTHM PHARMACEUTICALS INC. | RYTM | Mazabraud Yann EVP, Head of International | 46,625 | $0 | 91,530 (Direct) | View |
| 2026-07-01 Tax Withholding | 2026-07-02 4:52 pm | N/A N/A | RHYTHM PHARMACEUTICALS INC. | RYTM | Garfield Alastair Chief Scientific Officer | 2,150 | $110.41 | 18,946 (Direct) | View |
| 2026-07-01 Exercise | 2026-07-02 4:52 pm | N/A N/A | RHYTHM PHARMACEUTICALS INC. | RYTM | Garfield Alastair Chief Scientific Officer | 4,445 | $0 | 18,946 (Direct) | View |
| 2026-06-24 Option Award | 2026-06-25 6:09 pm | N/A 2036-06-23 | RHYTHM PHARMACEUTICALS INC. | RYTM | JEAN CHRISTOPHE Director | 6,015 | $0 | 17,727 (Direct) | View |
| 2026-06-23 Exercise | 2026-06-25 6:09 pm | N/A N/A | RHYTHM PHARMACEUTICALS INC. | RYTM | JEAN CHRISTOPHE Director | 4,712 | $0 | 17,727 (Direct) | View |
| 2026-06-24 Option Award | 2026-06-25 6:08 pm | N/A 2036-06-23 | RHYTHM PHARMACEUTICALS INC. | RYTM | MCGIRR DAVID W J Director | 6,015 | $0 | 17,727 (Direct) | View |
| 2026-06-23 Exercise | 2026-06-25 6:08 pm | N/A N/A | RHYTHM PHARMACEUTICALS INC. | RYTM | MCGIRR DAVID W J Director | 4,712 | $0 | 17,727 (Direct) | View |
| 2026-06-24 Option Award | 2026-06-25 6:06 pm | N/A 2036-06-23 | RHYTHM PHARMACEUTICALS INC. | RYTM | TETRAULT LYNN A. Director | 6,015 | $0 | 17,727 (Direct) | View |
| 2026-06-23 Exercise | 2026-06-25 6:06 pm | N/A N/A | RHYTHM PHARMACEUTICALS INC. | RYTM | TETRAULT LYNN A. Director | 4,712 | $0 | 17,727 (Direct) | View |
| 2026-06-24 Option Award | 2026-06-25 6:03 pm | N/A 2036-06-23 | RHYTHM PHARMACEUTICALS INC. | RYTM | Arbuckle Stuart A Director | 6,015 | $0 | 17,727 (Direct) | View |
| 2026-06-23 Exercise | 2026-06-25 6:03 pm | N/A N/A | RHYTHM PHARMACEUTICALS INC. | RYTM | Arbuckle Stuart A Director | 4,712 | $0 | 17,727 (Direct) | View |
| 2026-06-24 Option Award | 2026-06-25 6:01 pm | N/A 2036-06-23 | RHYTHM PHARMACEUTICALS INC. | RYTM | GOOD JENNIFER L Director | 6,015 | $0 | 17,727 (Direct) | View |
| 2026-06-23 Exercise | 2026-06-25 6:01 pm | N/A N/A | RHYTHM PHARMACEUTICALS INC. | RYTM | GOOD JENNIFER L Director | 4,712 | $0 | 17,727 (Direct) | View |
| 2026-06-22 Exercise | 2026-06-24 4:15 pm | N/A 2030-12-08 | RHYTHM PHARMACEUTICALS INC. | RYTM | TETRAULT LYNN A. Director | 37,000 | $0 | 7,000 (Direct) | View |
| 2026-06-22 Exercise | 2026-06-24 4:15 pm | N/A N/A | RHYTHM PHARMACEUTICALS INC. | RYTM | TETRAULT LYNN A. Director | 37,000 | $28.27 | 7,000 (Direct) | View |
| 2026-05-18 Exercise | 2026-05-20 4:15 pm | N/A N/A | RHYTHM PHARMACEUTICALS INC. | RYTM | Smith Hunter C Chief Financial Officer | 3,000 | $17.87 | 198,611 (Direct) | View |
| 2026-05-18 Exercise | 2026-05-20 4:15 pm | N/A 2030-02-13 | RHYTHM PHARMACEUTICALS INC. | RYTM | Smith Hunter C Chief Financial Officer | 3,000 | $0 | 198,611 (Direct) | View |
| 2026-05-15 Exercise | 2026-05-19 4:15 pm | N/A N/A | RHYTHM PHARMACEUTICALS INC. | RYTM | German Christopher Paul Corporate Controller & CAO | 1,406 | $17.97 | 8,739 (Direct) | View |
| 2026-05-15 Exercise | 2026-05-19 4:15 pm | N/A N/A | RHYTHM PHARMACEUTICALS INC. | RYTM | German Christopher Paul Corporate Controller & CAO | 1,687 | $56.69 | 8,739 (Direct) | View |
| 2026-05-15 Exercise | 2026-05-19 4:15 pm | N/A N/A | RHYTHM PHARMACEUTICALS INC. | RYTM | German Christopher Paul Corporate Controller & CAO | 1,349 | $49.23 | 8,739 (Direct) | View |
| 2026-05-15 Exercise | 2026-05-19 4:15 pm | N/A 2035-02-13 | RHYTHM PHARMACEUTICALS INC. | RYTM | German Christopher Paul Corporate Controller & CAO | 4,442 | $0 | 8,739 (Direct) | View |
| 2026-04-01 Exercise | 2026-04-03 5:36 pm | N/A N/A | RHYTHM PHARMACEUTICALS INC. | RYTM | Mazabraud Yann EVP, Head of International | 25,750 | $0 | 81,405 (Direct) | View |
| 2026-04-01 Option Award | 2026-04-03 5:35 pm | N/A N/A | RHYTHM PHARMACEUTICALS INC. | RYTM | Popovits Kimberly J Director | 17,065 | $0 | 17,065 (Direct) | View |
| 2026-03-12 Other | 2026-03-16 4:11 pm | N/A N/A | RHYTHM PHARMACEUTICALS INC. | RYTM | Mathers Edward T Director | 4,199 | $0 | 25,367 (Indirect) | View |
| 2026-03-04 Exercise | 2026-03-06 4:51 pm | N/A N/A | RHYTHM PHARMACEUTICALS INC. | RYTM | German Christopher Paul Corporate Controller & CAO | 1,500 | $17.97 | 3,891 (Direct) | View |
| 2026-03-04 Exercise | 2026-03-06 4:51 pm | N/A 2033-04-03 | RHYTHM PHARMACEUTICALS INC. | RYTM | German Christopher Paul Corporate Controller & CAO | 1,500 | $0 | 3,891 (Direct) | View |
| 2026-03-02 Option Award | 2026-03-04 8:22 pm | N/A 2036-03-01 | RHYTHM PHARMACEUTICALS INC. | RYTM | Mazabraud Yann EVP, Head of International | 35,000 | $0 | 35,000 (Direct) | View |
| 2026-03-02 Other | 2026-03-04 4:40 pm | N/A N/A | RHYTHM PHARMACEUTICALS INC. | RYTM | Mathers Edward T Director | 4,198 | $0 | 21,167 (Indirect) | View |
| 2026-03-01 Tax Withholding | 2026-03-03 7:45 pm | N/A N/A | RHYTHM PHARMACEUTICALS INC. | RYTM | German Christopher Paul Corporate Controller & CAO | 342 | $94.94 | 5,415 (Direct) | View |
| 2026-03-01 Exercise | 2026-03-03 7:45 pm | N/A N/A | RHYTHM PHARMACEUTICALS INC. | RYTM | German Christopher Paul Corporate Controller & CAO | 1,162 | $0 | 5,415 (Direct) | View |
| 2026-03-02 Exercise | 2026-03-02 8:56 pm | N/A N/A | RHYTHM PHARMACEUTICALS INC. | RYTM | Smith Hunter C Chief Financial Officer | 6,099 | $6.8 | 208,012 (Direct) | View |
| 2026-03-02 Exercise | 2026-03-02 8:56 pm | N/A 2032-02-08 | RHYTHM PHARMACEUTICALS INC. | RYTM | Smith Hunter C Chief Financial Officer | 6,099 | $0 | 208,012 (Direct) | View |
| 2026-02-14 Exercise | 2026-02-18 4:30 pm | N/A N/A | RHYTHM PHARMACEUTICALS INC. | RYTM | Mazabraud Yann EVP, Head of International | 10,000 | $0 | 83,155 (Direct) | View |
| 2026-02-11 Option Award | 2026-02-13 5:53 pm | N/A N/A | RHYTHM PHARMACEUTICALS INC. | RYTM | Shulman Joseph Chief Technical Officer | 37,500 | $0 | 37,500 (Direct) | View |
| 2026-02-11 Option Award | 2026-02-13 5:52 pm | N/A N/A | RHYTHM PHARMACEUTICALS INC. | RYTM | Meeker David P President and CEO | 179,750 | $0 | 179,750 (Direct) | View |
| 2026-02-11 Option Award | 2026-02-13 5:50 pm | N/A N/A | RHYTHM PHARMACEUTICALS INC. | RYTM | Mazabraud Yann EVP, Head of International | 23,350 | $0 | 23,350 (Direct) | View |
| 2026-02-11 Option Award | 2026-02-13 5:49 pm | N/A N/A | RHYTHM PHARMACEUTICALS INC. | RYTM | Lee Jennifer Kayden EVP, Head of North America | 54,150 | $0 | 54,150 (Direct) | View |
| 2026-02-11 Option Award | 2026-02-13 5:48 pm | N/A N/A | RHYTHM PHARMACEUTICALS INC. | RYTM | German Christopher Paul Corporate Controller & CAO | 5,215 | $0 | 5,215 (Direct) | View |
| 2026-02-11 Option Award | 2026-02-13 5:47 pm | N/A N/A | RHYTHM PHARMACEUTICALS INC. | RYTM | Garfield Alastair Chief Scientific Officer | 41,650 | $0 | 41,650 (Direct) | View |
| 2026-02-11 Option Award | 2026-02-13 5:45 pm | N/A N/A | RHYTHM PHARMACEUTICALS INC. | RYTM | Cramer Pamela J. Chief Human Resources Officer | 29,150 | $0 | 29,150 (Direct) | View |
| 2026-02-11 Option Award | 2026-02-12 8:56 pm | N/A N/A | RHYTHM PHARMACEUTICALS INC. | RYTM | Smith Hunter C Chief Financial Officer | 62,500 | $0 | 180,966 (Direct) | View |
| 2026-02-01 Exercise | 2026-02-03 4:38 pm | N/A N/A | RHYTHM PHARMACEUTICALS INC. | RYTM | Mazabraud Yann EVP, Head of International | 5,500 | $0 | 54,155 (Direct) | View |
| 2026-02-01 Exercise | 2026-02-03 4:36 pm | N/A N/A | RHYTHM PHARMACEUTICALS INC. | RYTM | Smith Hunter C Chief Financial Officer | 52,000 | $0 | 181,527 (Direct) | View |
| 2026-02-01 Tax Withholding | 2026-02-03 4:36 pm | N/A N/A | RHYTHM PHARMACEUTICALS INC. | RYTM | Smith Hunter C Chief Financial Officer | 10,750 | $108.99 | 181,527 (Direct) | View |
| 2026-02-01 Exercise | 2026-02-03 4:35 pm | N/A N/A | RHYTHM PHARMACEUTICALS INC. | RYTM | Shulman Joseph Chief Technical Officer | 33,936 | $0 | 49,907 (Direct) | View |
| 2026-02-01 Tax Withholding | 2026-02-03 4:35 pm | N/A N/A | RHYTHM PHARMACEUTICALS INC. | RYTM | Shulman Joseph Chief Technical Officer | 6,507 | $108.99 | 49,907 (Direct) | View |
| 2026-02-01 Exercise | 2026-02-03 4:34 pm | N/A N/A | RHYTHM PHARMACEUTICALS INC. | RYTM | Meeker David P President and CEO | 137,426 | $0 | 395,653 (Direct) | View |
| 2026-02-01 Tax Withholding | 2026-02-03 4:34 pm | N/A N/A | RHYTHM PHARMACEUTICALS INC. | RYTM | Meeker David P President and CEO | 31,522 | $108.99 | 395,653 (Direct) | View |